Sunday, April 20, 2008

NASA loses its (science) head, Pfizer loses its case
[This is my Lab Report column for the May issue of Prospect.]

The resignation of NASA’s science chief Alan Stern in April is a symptom of all that’s wrong with the US space agency. Stern has given no official reason for his abrupt departure, which of course makes it seem all the more that the reason is one he’d rather not talk about. Many suspect his decision stems from a frustrating relationship with NASA’s leadership, specifically its head Mike Griffin, despite Stern’s assertion that Griffin is “the best administrator NASA has ever had”. Stern’s aim to keep projects on schedule and within budget – both persistent problems for NASA – is hard to fault, but it has sometimes caused a collision of priorities.

A highly respected planetary scientist, Stern has been seen as a true voice of science at NASA, favouring projects that actually teach us something about the universe. But increasingly, NASA seems compelled to support popular programmes that pander to the romanticised American vision of space exploration. Griffin has frozen the budget for fundamental science to fund a manned return mission to the moon – a political rather than scientific venture. Stern also tried to reduce the focus of planetary missions on Mars at the expense of the outer planets.

The crunch seems to have come over Stern’s decision in March to shut down Opportunity, one of the two Mars rovers currently exploring the planet’s surface. Griffin was not informed of that decision, and when he found out, he reversed it. Whatever the demands of etiquette, Stern’s decision made sense: the rovers have been an immensely successful testament to the power of robotic exploration, but they have long fulfilled their objectives. Opportunity and Spirit can still gather useful data, but the real problem was that the public loves them: the planned shutdown became headline news and provoked objections in Congress.

The rovers are now portrayed like pets: newspapers talked about Opportunity being ‘put to sleep’ rather than switched off. This pathetic fallacy is a projection of the longing to put humans on Mars. The irony is that a populist commitment to cripplingly expensive human spaceflight projects will ultimately give the taxpayer far less value for money than the kind of missions Stern supported. For now, that kind of absurd sentimentality has deprived NASA of a highly capable head of science.


When scientists submit papers for publication, they usually enter into an unwritten contract of confidentiality with the journal: the paper will not be disseminated outside of the peer review process, but the reviewers will not be disclosed to the authors.

The pharmaceutical company Pfizer has decided that this arrangement should be subordinate to its own interests. During a lawsuit last year over alleged side effects of its painkillers Celebrex and Bextra, it subpoenaed the New England Journal of Medicine (NEJM) to release the reviews and reviewers’ identities for papers published on the drugs, along with details of the journals’ internal editorial deliberations. The NEJM’s refusal has now been upheld by a federal court in Massachusetts.

Pfizer’s lawyers say that the information could help to exonerate the company in deciding to put the drugs on sale. Bextra was withdrawn in 2005 after claims that it could cause heart attacks and strokes; Celebrex remains on the market.

“The public has no interest in protecting the editorial process of a scientific journal”, the lawyers have say. But the public has every interest in knowing that scientific claims will be checked out by independent experts who not only are guaranteed anonymity but do not expose themselves to the danger of litigation. The best reviewers might otherwise decline the task rather than take that risk. A counter-argument is that information relevant to public health should not be kept confidential – but drug companies are after all under no obligation to disclose their own tests and trials.

Besides, Pfizer has not specified what it hoped to find in the documents. One interpretation is that the company is simply fishing for anything that might help its case, rather than acting on a belief that the NEJM holds some pivotal evidence. The court’s decision is the right one, but will it persuade drug companies that they cannot rewrite the rules by which science is conducted?


The new head of the Human Fertilisation and Embryology Authority (HFEA), Renaissance historian Lisa Jardine, has certainly begun her role during ‘interesting times’. The impending vote on the Human Fertilisation and Embryology Bill crystallizes several moral dilemmas about today’s research and practice in these areas, and threatens to heighten the polarization they induce. Whatever positions Jardine takes are sure to upset some vocal group or other.

Perhaps this is why the appointment of someone used to taking the long view, and accustomed also to the hard knocks of public life, makes sense. Certainly, Jardine’s popularizing instincts seem right for the HFEA just now: she considers public education about fertility issues (“something people need to know about”) as important as the regulatory responsibilities. The HFEA, while not exactly an opaque bureaucracy, has seldom previously shown an explicit commitment to inform.

And now is the time to do it. So far, it seems that the kind of misinformation about the bill spread by Catholic officials and other religious groups – talk of animal-human ‘cybrid’ embryos in research as ‘of Frankenstein proportion’ – has not significantly dented a public appreciation of the benefits such research could bring. (The ‘animal’ component here is a mere shell for human genes.) But it’s never a good idea to underestimate the determination of zealots.


Anonymous said...

歐美a免費線上看,熊貓貼圖區,ec成人,聊天室080,aaa片免費看短片,dodo豆豆聊天室,一對一電話視訊聊天,自拍圖片集,走光露點,123456免費電影,本土自拍,美女裸體寫真,影片轉檔程式,成人視訊聊天,貼圖俱樂部,辣妹自拍影片,自拍電影免費下載,電話辣妹視訊,情色自拍貼圖,卡通做愛影片下載,日本辣妹自拍全裸,美女裸體模特兒,showlive影音聊天網,日本美女寫真,色情網,台灣自拍貼圖,情色貼圖貼片,百分百成人圖片 ,情色網站,a片網站,ukiss聊天室,卡通成人網,3級女星寫真,080 苗栗人聊天室,成人情色小說,免費成人片觀賞,

傑克論壇,維納斯成人用品,免費漫畫,內衣廣告美女,免費成人影城,a漫,國中女孩寫真自拍照片,ut男同志聊天室,女優,網友自拍,aa片免費看影片,玩美女人短片試看片,草莓論壇,kiss911貼圖片區,免費電影,免費成人,歐美 性感 美女 桌布,視訊交友高雄網,工藤靜香寫真集,金瓶梅免費影片,成人圖片 ,女明星裸體寫真,台灣處女貼圖貼片區,成人小遊戲,布蘭妮貼圖片區,美女視訊聊天,免費情色卡通短片,免費av18禁影片,小高聊天室,小老鼠論壇,免費a長片線上看,真愛love777聊天室,聊天ukiss,情色自拍貼圖,寵物女孩自拍網,免費a片下載,日本情色寫真,美女內衣秀,色情網,

Anonymous said...


女優王國,免費無碼a片,0800a片區,免費線上遊戲,無名正妹牆,成人圖片,寫真美女,av1688影音娛樂網,dodo豆豆聊天室,網拍模特兒,成人文學,免費試看a片,a片免費看,成人情色小說,美腿絲襪,影片下載,美女a片,人體寫真模特兒,熊貓成人貼,kiss情色,美女遊戲區,104 貼圖區,線上看,aaa片免費看影片,天堂情色,躺伯虎聊天室,洪爺情色網,kiss情色網,貼影區,雄貓貼圖,080苗栗人聊天室,都都成人站,尋夢園聊天室,a片線上觀看,無碼影片,情慾自拍,免費成人片,影音城論壇,情色成人,最新免費線上遊戲,a383影音城,美腿,色情寫真,xxx383成人視訊,視訊交友90739,av女優影片,